跳转至内容
Merck
CN

EHU015741

Sigma-Aldrich

MISSION® esiRNA

targeting human TFPI2

登录查看公司和协议定价


About This Item

UNSPSC代码:
41105324
NACRES:
NA.51

描述

Powered by Eupheria Biotech

质量水平

产品线

MISSION®

形式

lyophilized powder

esiRNA cDNA靶序列

GCTGTGGAGGGAATGACAATAACTTTGTTAGCAGGGAGGATTGCAAACGTGCATGTGCAAAAGCTTTGAAAAAGAAAAAGAAGATGCCAAAGCTTCGCTTTGCCAGTAGAATCCGGAAAATTCGGAAGAAGCAATTTTAAACATTCTTAATATGTCATCTTGTTTGTCTTTATGGCTTATTTGCCTTTATGGTTGTATCTGAAGAATAATATGACAGCATGAGGAAACAAATCATTGGTGATTTATTCACCAGTTTTTATTAATACAAGTCACTTTTTAAAAAATTTGGATTTTTTTATATATAACTAGCTGCTATTCAAATGTGAGTCTACCATTTTTAATTTATGGTTCAACTGTTTGTGAGACTGAATTCTTGCAATGCATAAGATATAAAAGCAAATATGACTCACTCATTTCTTGGGGTCGT

基因组数据库 |人类登记号

NCBI登记号

运输

ambient

储存温度

−20°C

基因信息

相关类别

一般描述

MISSION® shRNA是核糖核酸内切酶制备的siRNA。它们是靶向相同mRNA序列的siRNA异质混合物。这些多重沉默触发(multiple silencing trigger)导致高度特异性的、有效的基因沉默。

如需其他详细信息并查看所有可用的esiRNA选项,请访问SigmaAldrich.com/esiRNA

法律信息

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

新产品

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Chiun-Wei Huang et al.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 34(7), 9678-9693 (2020-05-30)
Glioblastoma multiforme is the most common and aggressive glial tumor with poor prognosis. Importantly, effective treatment options for glioblastoma are unmet needs. Obesity and low physical activity have been linked with a high risk of cancer, and exercise is related
Muraly Puttabyatappa et al.
Endocrinology, 158(1), 109-120 (2016-11-05)
Increased proteolytic activity is a key event that aids in breakdown of the follicular wall to permit oocyte release. How the protease activity is regulated is still unknown. We hypothesize that tissue factor pathway inhibitor 2 (TFPI2), a Kunitz-type serine

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门